Navigation Links
ETHICON Launches the Latest Innovation in Hernia Repair Platform; PROCEED(TM) Ventral Patch (PVP(TM) Device)
Date:12/16/2008

New System Capitalizes on Innovative Materials and Technology

SOMERVILLE, N.J., Dec. 16 /PRNewswire/ -- ETHICON, INC, a global medical device company, today announced the launch of the PROCEED Ventral Patch (PVP Device), the latest addition to its family of hernia products. PVP Device is the first and only umbilical hernia repair device featuring lighter-weight mesh and exclusive, absorbable deployment technology. It is indicated for use in umbilical, epigastric, small ventral and trocar site hernias.

Hernias are extremely common. Umbilical hernias occur near the belly button or navel, which has a natural weakness from the blood vessels of the umbilical cord. These hernias may occur in infants at or just after birth, and may resolve at 3 or 4 years of age. However, the area of weakness can persist throughout life and can occur in men, women, and children at any time. In adults, umbilical hernias will not resolve and may progressively worsen over time. They are sometimes caused by abdominal pressure due to being overweight, excessive coughing, or pregnancy.

The PROCEED Ventral Patch is a sterile, self-expanding, partially absorbable, flexible mesh device that utilizes the proven design of PROCEED Surgical Mesh. The unique product design offers surgeons secure and stable deployment,(1) strength without ePTFE (expanded polytetrafluoroethylene),(2) and a macroporous / partially absorbable construction.(3) The PVP Device is available in small (4.3 cm) and medium (6.4 cm) sizes.

Dr. Carl Doerhoff, the first surgeon to implant the PVP Device in a human patient in the US, stated, "I'm very excited about the new technology advancements present in the PVP Device. Knowing that the product is flexible and partially absorbable for a greater likelihood of long-term patient comfort is an added benefit."

The PROCEED Ventral Patch is made by ETHICON, INC., a Johnson & Johnson company. ETHICON continues Johnson & Johnson's 100-year commitment to wound care today with innovative products for general surgery, wound management, women's health and urology, and wound closure. For more information about ETHICON visit www.ethicon.com.

(1) Data on file. ETHICON, INC.

(2) Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia. 2001;5(3):142-147.

(3) Harrell AG, Novitsky YW, Cristiano JA, et al. Prospective histologic evaluation of intra-abdominal prosthetics four months after implantation in a rabbit model. Surg Endosc. 2007;21:1170-1174.

    Contact:    Michelle Bauman
                (908) 218-2463
                ETHICON, Inc.
                mbauman@its.jnj.com


'/>"/>
SOURCE ETHICON, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System
2. ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
3. ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners
4. Board-Certified Bariatric Surgeon, Trace Curry, MD Places First Next-Generation Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band-C in Ohio
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. UPMC Health Plan Launches New Personal Health Record
7. HealthInsuranceFinders.com Launches Video Contest for Young Directors
8. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
9. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
10. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
11. Mannatech Launches Phase One of New Sales and Training Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 04, 2016 , ... Safety ... global construction firms representing the Construction Industry Safety Initiative (CISI) and the Incident ... purpose: to inspire everyone in the industry to be leaders in safety. Statistics ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association ... into its VIP Woman of the Year Circle. She is recognized with this prestigious ... professional women, boasting more than 850,000 members and over 200 operating Local Chapters. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Redondo Beach, CA (PRWEB) , ... May 03, 2016 , ... ... together online to help cancer patients and their families move toward recovery and is ... the focus of today's Dr. Carol Francis Talk Radio show considering medical ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: